Dietary or pharmacological interventions targeting lysine intake or HDAC activity could recalibrate crotonylation dynamics, potentially disrupting TAM recruitment and polarization to enhance immunotherapy efficacy in glioma. Here, HDAC9 is linked to central nervous system cancer.